Equity
€1,656 from €157,135 in 2023
Equity fell by 99% in 2 years.
JUVENTAS
Lifetime
6 annual accounts with figures on one time axispeak €168,643 (2021)
€68,957▼ 1.7%
lowest -€4,072 (2022)
€21,998▼ 24.3%
peak €157,135 (2023)
€1,656▼ 47.6%
€76,575▼ 10.6%
Board1 name since 2020
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €23,500Equity from €3,158 to €1,656Investments €25,276Cash from €31,348 to €2,401
Key points
from the 2025 annual accountsDebts
€76,575 98% of the balance sheet
Financial debts 30%Suppliers 8%Taxes and wages 21%Other 41%
Of this, €59,186 falls due within a year.
Investments
€25,276 3.2 × depreciation
Green is investment, beige is depreciation.
Filings
6 annual accounts 4 late
The 2021 accounts came latest: 30 days after the end of the period.
At the same address
33 companies
Position in the sector
€1,656
Less equity than 94% of companies in human health. Sector median €125,064 · 21,313 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,153 companies had the same profile as JUVENTAS has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,153 companies, not a prediction for JUVENTAS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0748622838
Incorporation
Founding capital of €1,600, 100 shares · Founders: and · Appointment: (director) · published on 18-06-2020 · Gazette deed
First establishment
Louizalaan 284, Ixelles
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| JUVENTAS Brussels | €78,231 | €68,957 | 2.1% | - |
| JUNGLE PEACE Burdinne | €81,085 | €70,059 | 92.7% | - |
| MEDICA-ONE Chaudfontaine | €80,136 | €65,165 | 11.4% | - |
| DOCTEUR OLIVIER BONHOMME, PNEUMOLOGIE Blegny | €84,964 | €66,359 | 2.4% | - |
| Docteur Thomas OTTE Nassogne | €69,802 | €66,068 | 71.3% | - |
| Dr. Laura Abbeel Antwerp | €80,633 | €64,003 | 6.2% | - |
| DERMA-TO Wezembeek-Oppem | €88,276 | €74,909 | 1.1% | - |
These companies have the same main activity as JUVENTAS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €69,800 and €88,300, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 16-06-2020Normal situation
- Registered office
- 35 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 12 November 2026.
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 2021
- Establishment unit
- 2.304.738.2121050 Ixelles, since 16-06-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2025
Annual accounts 2025
- ≈ €160,000estimated
- €78,231▼ 11.9%
- ≈ 0.5 FTEestimated
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on JUVENTAS
JUVENTAS files the micro format. That format states no turnover. The gross margin rose from €5,608 in 2020 to €68,957 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about JUVENTAS
- What is the company number of JUVENTAS?
- The company number of JUVENTAS is 0748.622.838. The VAT number is the same number with BE in front: BE 0748.622.838.
- Where is JUVENTAS based?
- The registered office is at Louizalaan 284, 1050 Brussels.Company details
- What does JUVENTAS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of JUVENTAS?
- JUVENTAS is a private limited company (BV).
- When was JUVENTAS founded?
- JUVENTAS was founded on 16-06-2020.
- Is JUVENTAS still active?
- Yes, JUVENTAS is an active enterprise in the KBO register.
- How many employees does JUVENTAS have?
- JUVENTAS had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- Which joint committee does JUVENTAS fall under?
- In its 2021 annual accounts, JUVENTAS states joint committee 330 (Health institutions and services).
- What is the turnover of JUVENTAS?
- The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €68,957 and 32 comparable companies (NACE 862). It probably lies between €120,000 and €200,000.
- Is JUVENTAS profitable?
- In financial year 2025, JUVENTAS made a profit of €21,998.
- Where can I find the annual accounts of JUVENTAS?
- JUVENTAS filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of JUVENTAS due?
- JUVENTAS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.